M. Ntreta

Azienda USL di Bologna

Papers

1

Total Citations

3

H-Index

1

About

M. Ntreta is a leading researcher in the application of machine learning to radiation oncology, with a primary focus on improving treatment outcomes for prostate cancer patients. Their most notable contribution is the development of the ICAROS Study, a multicenter machine learning-based predictive model that accurately forecasts acute gastrointestinal and genitourinary toxicity in patients undergoing salvage radiotherapy after prostatectomy. By identifying key prognostic factors through advanced computational techniques, Ntreta’s work enables more personalized treatment planning, reducing the risk of severe side effects. This groundbreaking research, published in 2025, has already garnered 3 citations, signaling its rapid impact on clinical practice. Ntreta’s achievements highlight a commitment to integrating artificial intelligence into oncology, offering a data-driven approach to enhance patient quality of life. Their work stands as a pivotal step toward precision medicine in radiotherapy, making them a key figure in the intersection of machine learning and cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
A Multicenter Machine Learning-Based Predictive Model of Acute Toxicity in Prostate Cancer Patients Undergoing Salvage Radiotherapy (ICAROS Study)
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Azienda USL di Bologna

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago